[go: up one dir, main page]

EA200601853A1 - TREATMENT OF DISTURBED RESPIRATORY FUNCTION - Google Patents

TREATMENT OF DISTURBED RESPIRATORY FUNCTION

Info

Publication number
EA200601853A1
EA200601853A1 EA200601853A EA200601853A EA200601853A1 EA 200601853 A1 EA200601853 A1 EA 200601853A1 EA 200601853 A EA200601853 A EA 200601853A EA 200601853 A EA200601853 A EA 200601853A EA 200601853 A1 EA200601853 A1 EA 200601853A1
Authority
EA
Eurasian Patent Office
Prior art keywords
respiratory function
treatment
sleep apnea
disturbed respiratory
disturbed
Prior art date
Application number
EA200601853A
Other languages
Russian (ru)
Inventor
Йонас Лундаль
Бьярке Эберт
Ян Хеднер
Original Assignee
Х. Лундбекк А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Х. Лундбекк А/С filed Critical Х. Лундбекк А/С
Priority claimed from PCT/DK2005/000222 external-priority patent/WO2005094820A1/en
Publication of EA200601853A1 publication Critical patent/EA200601853A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Настоящее изобретение относится к способу лечения нарушенной дыхательной функции у пациента, страдающего апноэ во сне, такого как центральное апноэ во сне или обструктивное апноэ во сне, включающему введение указанному пациенту эффективного количества габоксадола в сутки.The present invention relates to a method of treating impaired respiratory function in a patient suffering from sleep apnea, such as central sleep apnea or obstructive sleep apnea, comprising administering to the patient an effective amount of gaboxadol per day.

EA200601853A 2004-04-02 2005-03-31 TREATMENT OF DISTURBED RESPIRATORY FUNCTION EA200601853A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200400540 2004-04-02
PCT/DK2005/000222 WO2005094820A1 (en) 2004-04-02 2005-03-31 Treatment of impaired respiratory function with gaboxadol

Publications (1)

Publication Number Publication Date
EA200601853A1 true EA200601853A1 (en) 2007-02-27

Family

ID=36608890

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200601853A EA200601853A1 (en) 2004-04-02 2005-03-31 TREATMENT OF DISTURBED RESPIRATORY FUNCTION

Country Status (6)

Country Link
KR (1) KR20070010136A (en)
CN (1) CN1942185A (en)
AR (1) AR048460A1 (en)
EA (1) EA200601853A1 (en)
IL (1) IL178289A0 (en)
ZA (1) ZA200607427B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20240160666A (en) * 2015-07-17 2024-11-11 오비드 테라퓨틱스 인크. Methods of treating developmental disorders with gaboxadol
AU2018309049A1 (en) * 2017-08-04 2020-02-27 Ovid Therapeutics Inc. Use of gaboxadol in the treatment of diabetes and related conditions
EP3883566A4 (en) 2018-11-21 2022-09-07 Certego Therapeutics Inc. GABOXADOL FOR SUICIDE RISK REDUCTION AND RAPID DEPRESSION RELIEF

Also Published As

Publication number Publication date
ZA200607427B (en) 2009-02-25
CN1942185A (en) 2007-04-04
AR048460A1 (en) 2006-04-26
IL178289A0 (en) 2007-03-08
KR20070010136A (en) 2007-01-22

Similar Documents

Publication Publication Date Title
WO2006023703A3 (en) Method for treating sleep related breathing disorders
ATE376828T1 (en) USE OF ROTIGOTINE FOR THE TREATMENT AND PREVENTION OF PARKINSON PLUS SYNDROME
WO2008048471A3 (en) Obstructive sleep apnea treatment devices, systems and methods
MX2010002498A (en) Methods of treating or preventing respiratory tract infection comprising administering cholecalciferol.
TW200738242A (en) Dihydropteridinones in the treatment of respiratory diseases
WO2007087468A3 (en) Adiponectin for treatment of various disorders
TNSN07263A1 (en) Substituted 4-phenyl tetrahydroisoquinolines, methods for producing them, their use as drug, and drug containing them
EA201791669A2 (en) NEW THERAPEUTIC APPROACHES IN THE TREATMENT OF SMT AND RELATED DISORDERS
MY156243A (en) Treatment for diabetes in patients inappropriate for metformin therapy
SG179410A1 (en) Therapeutic uses of inhibitors of rtp801
MX2009008825A (en) Novel methods.
UA85707C2 (en) Benzoxazines for treating respiratory tract diseases
MX2012007813A (en) Treatment of obstructive sleep apnea syndrome with a combination of a carbonic anhydrase inhibitor and an additional active agent.
IL192101A0 (en) Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
MX2007003157A (en) Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, their use as a medicament, and a medicament containing them.
EA200801033A1 (en) APPLICATION OF OLIGOURONATES FOR THE TREATMENT OF IMPROVED VISCOSITY OF SLIM
MY150702A (en) Substituted 4-phenyltetrahydroisoquinonelines, method of producing them, their use as medicament, and also medicament containing them
MY139498A (en) Composition, process of making, and medical use of substituted 4-phenyltetrahydroisoquinolines
BRPI0509210A (en) gaboxadol, and methods for treating impaired respiratory function, and sleep apnea
CY1110369T1 (en) NEW COOPERATIVE COMBINATION THAT INCLUDES Roflumilast And Formoterol
DK1030667T3 (en) Use of mirtazapine in the manufacture of a medicament for the treatment of sleep apnea
DK1715859T3 (en) Method of treating and diagnosing respiratory disorders in sleep by zonisamide and means for carrying out the method
MX2009003676A (en) S-nitrosothiol compounds and related derivatives.
EA200601853A1 (en) TREATMENT OF DISTURBED RESPIRATORY FUNCTION
ATE444754T1 (en) USE OF TYROSINKINASE INHIBITORS TO TREAT INFLAMMATORY PROCESSES